49 results
Page 2 of 3
20-F/A
0braib
23 Mar 15
Annual report (foreign) (amended)
12:00am
6-K
EX-1.1
wnlka9l4
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
424B3
njcvb8
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-10.1
futghl2v95qea74ui9z0
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
424B3
18arn3elqfa9
15 Oct 12
Prospectus supplement
12:00am
F-1
5z7st5 56
2 Oct 12
Registration statement (foreign)
12:00am
424B3
5c6ij5wrr618ubsbf
28 Mar 12
Prospectus supplement
12:00am
20-F
ornii
22 Mar 12
Annual report (foreign)
12:00am
6-K
EX-99.2
alpfu7uhfha023zzjx8
16 Feb 12
Current Report, Foreign Issuer
12:00am
20FR12B/A
mjr62dh o34xrnf2
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
EX-4.2
s0u8mg942g bgz
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.1
j123c
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.3
3kig0fcs9qn1v25r
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am